CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis

Multiple sclerosis (MS) is an immune-mediated disease that damages myelin in the central nervous system (CNS). We investigated the profile of CCN3, a known regulator of immune function and a potential mediator...

Source: Journal of Neuroinflammation - November 22, 2020 Category: Neurology Authors: Michelle Naughton, Jill Moffat, George Eleftheriadis, Nira de la Vega Gallardo, Andrew Young, John Falconer, Kristen Hawkins, Ben Pearson, Bernard Perbal, Andrew Hogan, Paul Moynagh, Sam Loveless, Neil P. Robertson, Bruno Gran, Rachael Kee, Stella Hughes Tags: Research Source Type: research